Computed tomography imaging for each case prior to ibrutinib exposure, during pneumonitis while on ibrutinib, and following ibrutinib discontinuation. (A,D,G,J) Pre-ibrutinib; (B,E,H,K) during ibrutinib; (C,F,I,L) post-ibrutinib.